logo-loader
viewBalchem Corporation

Balchem Corporation Reports Record Earnings

full_year_results_350_4c58419a734c9.jpg

For the quarter ended June 30, 2010, Balchem Corporation (Nasdaq:BCPC) reported record net earnings of US$8.3 million, an increase of 21.4% over the same period in 2009 while net sales rose by 16% to $61.5 million. As a result, diluted net earnings per share increased 16.7% to $0.28 from $0.24 for the same period the previous year.  Balchem attributed the strong growth in revenues and earnings to a strong quarter for its Food, Pharma & Nutrition segment, and its continued focus on both organic and acquisitive growth.


All three of Balchem`s segments exhibited strong sales growth for the quarter.


 The Food, Pharma & Nutrition segment, which provides granulation and agglomeration solutions to human food, grew sales by 16.4% from last year`s comparable quarter to $10.6 million.


The Animal Nutrition & Health segment, a manufacturer and supplier of animal health products, posted a 16.8% sales increase from last year`s comparable quarter to $5.9 million. 


The ARC Specialty Products segment, which provides specialty chemicals for the healthcare industry, increased sales by 12.4% from last year`s comparable quarter to $10.2 million. 


For the six months ended June 30, 2010, Balchem posted $121.4 million in consolidated sales, a 14.5% increase from the same period the previous year.  Net earnings for the same period increased 18.4% to $15.4 million, while diluted earnings per share increased to $0.52 from $0.45. 


Balchem`s balance sheet  stayed healthy as its cash balance increased from $46.4 million in December to $50.4 million on June 30, with a net working capital of $77.1 million.  


 Dino A. Rossi, Balchem`s CEO, expressed optimism for the rest of 2010 as the global economy shows signs of improvement and expects continued improvements in sales and net earnings . 
Blachem rose 1.3% on the NASDAQ against a falling market.

Quick facts: Balchem Corporation

Price: 94.35 USD

NASDAQ:BCPC
Market: NASDAQ
Market Cap: $3.05 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian Vanadium confirms ‘exceptional’ vanadium extraction in test work

Australian Vanadium Ltd (ASX:AVL) (OTCMKTS:ATVVF) managing director Vincent Algar speaks to Proactive about recent pilot test-work conducted at the Australian Vanadium Project, which delivered leach extraction of up to 94.7%. The pilot-scale roast and leach testing has confirmed the...

22 hours, 43 minutes ago

2 min read